ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs ...
ADC Therapeutics expects to generate annualized cost savings of about $10 million and incur one-time pre-tax charges of about ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results